# Perejil del Cerro (Apeiba tibourbou)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/perejil-del-cerro-apeiba-tibourbou
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Apeiba tibourbou Aubl., Perejil del Cerro, Mountain Parsley Tree, Tibourbou, Apeiba aspera

## Overview

Perejil del Cerro leaf extracts contain the phenolic compounds caffeic acid (approximately 0.04% yield under optimized extraction) and rosmarinic acid (approximately 1.89% yield), which are associated with [antioxidant](/ingredients/condition/antioxidant) free-radical scavenging activity, alongside traditional phytochemicals including saponins, ursolic acid, sesquiterpenic lactones, and cyanogenic glycosides. Evidence for its digestive, [anti-inflammatory](/ingredients/condition/inflammation), and antihelminthic applications remains confined to ethnobotanical records and one laboratory extraction study, with no clinical trials published to substantiate efficacy in humans.

## Health Benefits

- **Digestive Support**: Traditionally used as a digestive aid and against dysentery and diarrhea; saponins and phenolic compounds in leaf extracts may help modulate gut motility and reduce intestinal inflammation, though clinical validation is absent.
- **Antihelminthic Activity**: Ethnobotanical records from Central and South America document use of root decoctions against intestinal parasites; cyanogenic glycosides and saponins are candidate compounds hypothesized to disrupt parasite membrane integrity, but this has not been experimentally confirmed.
- **[Anti-inflammatory](/ingredients/condition/inflammation) Effects**: Traditional use for bruises, wounds, and general inflammation is supported by the presence of ursolic acid and rosmarinic acid, both of which have well-characterized anti-inflammatory activities in other botanical contexts, though direct evidence for this species is lacking.
- **Expectorant and Respiratory Relief**: Flower infusions and syrups are used traditionally to address stubborn cough and respiratory congestion; sesquiterpenic lactones and saponins are structurally consistent with mucolytic and expectorant properties documented in related compounds.
- **[Hepatoprotective](/ingredients/condition/detox) and Antipyretic Use**: Traditional healers employ the plant for hepatic diseases and fever reduction; ursolic acid present in leaves has demonstrated hepatoprotective and antipyretic properties in other plant species, offering a plausible mechanistic basis pending direct study.
- **Antioxidant Capacity**: Ultrasound-assisted extraction at 42°C with 30% alcohol for 24 minutes yields rosmarinic acid at 1.89% and caffeic acid at 0.04%, both potent free-radical scavengers that may reduce [oxidative stress](/ingredients/condition/antioxidant) in tissues, as characterized in vitro.
- **Wound Healing Potential**: Topical application of plant preparations is described in traditional practice for wounds and bruises; phenolic acids and ursolic acid are consistent with tissue-repair and [antimicrobial](/ingredients/condition/immune-support) properties, though no wound-healing studies specific to this species have been published.

## Mechanism of Action

The primary documented bioactive compounds in Apeiba tibourbou leaves are rosmarinic acid and caffeic acid, both hydroxycinnamic acid derivatives that neutralize [reactive oxygen species](/ingredients/condition/antioxidant) through direct hydrogen atom transfer and single-electron transfer mechanisms, reducing lipid peroxidation and protecting cellular macromolecules from oxidative damage. Ursolic acid, a pentacyclic triterpenoid also identified in leaf extracts, is known in related botanical studies to inhibit NF-κB signaling and cyclooxygenase (COX-1 and COX-2) enzyme activity, which would account for the reported [anti-inflammatory](/ingredients/condition/inflammation) and antipyretic traditional uses. Saponins present in the plant may act on cell membrane permeability, a mechanism consistent with antihelminthic and [antimicrobial](/ingredients/condition/immune-support) applications, while cyanogenic glycosides could contribute additional antiparasitic activity through localized hydrolysis releasing hydrogen cyanide under digestive conditions. Germacranolides and sesquiterpenic lactones, structural classes present in traditional reports of this species, have been shown in related genera to modulate inflammatory mediator release and inhibit smooth muscle activity, potentially underpinning the expectorant and antispasmodic traditional uses, though none of these pathways have been confirmed experimentally for A. tibourbou itself.

## Clinical Summary

There are no published clinical trials — neither randomized controlled trials, observational cohort studies, nor case series — evaluating the safety or efficacy of Apeiba tibourbou in human subjects. The entirety of health-related claims derives from ethnobotanical surveys documenting traditional use among communities in lowland Central and South America, particularly Panama and Colombia, for digestive disorders, parasitic infections, fever, respiratory ailments, and wound care. No effect sizes, dosage-response relationships, safety endpoints, or validated outcomes have been measured in a controlled setting, making it impossible to draw evidence-based conclusions about therapeutic benefit or harm. Given this evidentiary vacuum, Apeiba tibourbou should be regarded strictly as a plant of ethnopharmacological interest requiring systematic preclinical and, eventually, clinical investigation before any supplemental or medicinal use can be recommended with scientific confidence.

## Nutritional Profile

Formal nutritional profiling of Apeiba tibourbou has not been published, and no data on macronutrient or micronutrient content are available in the peer-reviewed literature. Phytochemical analysis of leaf extracts identifies rosmarinic acid as the dominant phenolic compound at approximately 1.89% yield under optimized extraction conditions, with caffeic acid present at approximately 0.04%; both are hydroxycinnamic acid derivatives with known [antioxidant](/ingredients/condition/antioxidant) capacity. Additional phytochemicals reported from traditional and ethnobotanical sources include ursolic acid (a pentacyclic triterpenoid), saponins (membrane-active glycosides), sesquiterpenic lactones, germacranolides, and cyanogenic glycosides, though quantitative concentrations for these secondary metabolites have not been determined analytically for this species. The Bligh and Dyer solvent extraction method has been identified as superior to other methods for recovering total lipids from leaf material, suggesting a non-trivial lipid fraction is present, but no fatty acid composition data have been published; bioavailability of all constituents remains uncharacterized.

## Dosage & Preparation

- **Root Decoction**: Boil 5g of root material (approximately three roots) in 1 liter of water for 1 hour; traditionally administered as 2 doses per day for antihelminthic and hepatic complaints; no standardized concentration or dose validation available.
- **Whole-Plant Decoction**: Entire plant boiled in water at unspecified proportions; dosage is not defined in available ethnobotanical records; used broadly for digestive and [anti-inflammatory](/ingredients/condition/inflammation) purposes.
- **Fresh-Plant Syrup**: Juice extracted from fresh plant material mixed with sugar and cooked for 10 minutes; recommended at 2–3 teaspoons per day for respiratory and expectorant use; no standardized sugar-to-juice ratio or active compound concentration established.
- **Flower Infusion**: 2 tablespoons of dried or fresh flowers steeped in 0.5 liters of boiling water for 5 minutes; consumed as 2–3 cups (approximately 8 fl oz each) daily for cough and respiratory symptoms; no clinical dose-finding study has been performed.
- **Standardized Extract (Research Use Only)**: Ultrasound-assisted extraction at 42°C, 30% ethanol, 24 minutes yields 1.89% rosmarinic acid and 0.04% caffeic acid per gram of leaf material; this method is used for laboratory characterization only and has not been translated into a commercial supplement form.
- **Caution**: No commercially standardized supplement form exists; all preparation methods are traditional and lack validated dosing, safety thresholds, or pharmacokinetic data.

## Safety & Drug Interactions

The primary documented contraindication for Apeiba tibourbou is existing biliary disease or biliary obstruction, as the plant is reported in traditional sources to stimulate bile production, which could exacerbate cholestatic conditions or biliary colic. No formal toxicological studies — including acute toxicity, subchronic toxicity, genotoxicity, or maximum tolerated dose assessments — have been published for any preparation of this species in animals or humans, leaving its safety profile largely unknown. The presence of cyanogenic glycosides in plant material is a potential safety concern, as these compounds can release hydrogen cyanide upon hydrolysis in the digestive tract, particularly in high-dose or prolonged use scenarios; however, no cases of toxicity attributable to A. tibourbou have been reported in the available literature. No drug interaction data are published, pregnancy and lactation safety have not been evaluated, and there are no established maximum safe doses; use during pregnancy, lactation, or in individuals with hepatobiliary disease should be avoided until safety data are available.

## Scientific Research

The published scientific literature on Apeiba tibourbou is extremely sparse, comprising primarily ethnobotanical compilations and a single laboratory study focused on optimizing ultrasound-assisted extraction conditions for phenolic compound recovery from leaf material, with no pharmacological, toxicological, or clinical investigations available. The extraction study established that conditions of 42°C, 30% ethanol, and 24 minutes of sonication yield maximal concentrations of rosmarinic acid (1.89%) and caffeic acid (0.04%), and noted that the Bligh and Dyer method was superior for total lipid extraction, but this work did not assess biological activity or safety endpoints. No in vitro cell-based assays, animal model studies, or human clinical trials have been published for any preparation of this species, meaning that all claimed health effects rest entirely on ethnobotanical documentation from traditional medicine communities in Panama and Colombia. The overall evidence base for Apeiba tibourbou must be rated as anecdotal and preliminary, with a significant need for basic pharmacological characterization before any therapeutic claims can be substantiated.

## Historical & Cultural Context

Apeiba tibourbou has been integrated into the traditional healing practices of indigenous and mestizo communities across the lowlands of Central and South America for generations, where the tree's rapid growth and accessibility in humid forests made it a readily available medicinal resource. In Panama, particularly in the Chiriquí and Boquete regions and among the Ngäbe-Buglé of Soloy, the plant is used under the common name 'Perejil del Cerro' (literally 'mountain parsley') for a wide spectrum of ailments including intestinal parasites, diarrhea, dysentery, fever, liver disease, and respiratory complaints, with preparations ranging from root boils to floral infusions. In Colombian traditional medicine, the plant is similarly associated with digestive and essential oil applications, and its bark and leaves are used in folk remedies for [inflammation](/ingredients/condition/inflammation) and external injuries such as bruises and wounds. While the species appears in several regional ethnobotanical compilations, it does not feature prominently in any major codified traditional medicine system such as Ayurveda or Traditional Chinese Medicine, and its medicinal knowledge is primarily oral and community-transmitted rather than documented in historical pharmacopoeias.

## Synergistic Combinations

No experimental synergy studies have been conducted for Apeiba tibourbou, but the rosmarinic acid and caffeic acid content of its leaf extracts suggest potential additive or synergistic [antioxidant activity](/ingredients/condition/antioxidant) when combined with other polyphenol-rich botanicals such as rosemary (Rosmarinus officinalis) or lemon balm (Melissa officinalis), which share these hydroxycinnamic acid constituents and act through overlapping free-radical scavenging pathways. The ursolic acid component may theoretically complement [anti-inflammatory](/ingredients/condition/inflammation) botanicals that target NF-κB or COX pathways, such as turmeric (Curcuma longa) or boswellia (Boswellia serrata), though no empirical testing of these combinations with A. tibourbou has been reported. Any synergistic applications remain speculative and are extrapolated from the known pharmacology of isolated compounds rather than from studies involving the whole plant extract.

## Frequently Asked Questions

### What is Perejil del Cerro used for traditionally?

Perejil del Cerro (Apeiba tibourbou) is used in traditional medicine across Panama and Colombia for digestive complaints including diarrhea and dysentery, intestinal parasites, liver disease, fever, stubborn cough, and inflammation from bruises and wounds. Preparations include root decoctions, flower infusions, and fresh-plant syrups, with dosing ranging from 2 cups of infusion daily to 2 doses of root decoction per day. All uses are ethnobotanical in origin and have not been validated by clinical trials.

### What are the active compounds in Apeiba tibourbou leaves?

The best-characterized active compounds in Apeiba tibourbou leaf extracts are rosmarinic acid, present at approximately 1.89% under optimized ultrasound-assisted extraction, and caffeic acid at approximately 0.04%, both of which are antioxidant phenolic acids. Traditional and ethnobotanical sources also report the presence of ursolic acid, saponins, sesquiterpenic lactones, germacranolides, and cyanogenic glycosides in the plant, though these have not been quantified analytically in published studies. No comprehensive phytochemical profile with validated concentrations is currently available for this species.

### Is Perejil del Cerro safe to use?

Perejil del Cerro is contraindicated for individuals with biliary problems, including gallbladder disease or bile duct obstruction, because it is reported to stimulate bile production. The plant contains cyanogenic glycosides, which are compounds that can release small amounts of hydrogen cyanide during digestion and may pose a risk at high doses or with prolonged use. No formal toxicological studies have been published, so safety cannot be confirmed for general use, and its use during pregnancy, breastfeeding, or alongside pharmaceutical medications is not advised without medical supervision.

### Are there any clinical trials on Apeiba tibourbou?

No clinical trials — including randomized controlled trials, observational studies, or animal pharmacology studies with quantified outcomes — have been published for Apeiba tibourbou as of the available literature. The scientific evidence for this plant is limited to a single laboratory study optimizing extraction conditions for phenolic compounds and several ethnobotanical surveys documenting traditional uses. All health claims associated with this plant remain unvalidated by controlled research, giving it an evidence score of 2 out of 10 on a standard clinical evidence scale.

### How is Perejil del Cerro prepared as a medicinal remedy?

Traditional preparations of Perejil del Cerro include a root decoction made by boiling 5g of root in 1 liter of water for one hour, taken twice daily, and a flower infusion prepared by steeping 2 tablespoons of flowers in half a liter of boiling water for 5 minutes, consumed as 2–3 cups per day. A syrup is also made by combining fresh plant juice with sugar and cooking for 10 minutes, taken at 2–3 teaspoons daily for respiratory complaints. None of these preparations have standardized active compound concentrations or clinically validated dosing regimens.

### Does Perejil del Cerro interact with antiparasitic or antimotility medications?

Perejil del Cerro has been traditionally used for antihelminthic purposes, which may theoretically potentiate prescription antiparasitic drugs like albendazole or mebendazole; concurrent use should be discussed with a healthcare provider to avoid redundant or excessive antiparasitic effects. Similarly, since the herb may influence gut motility via its saponin and phenolic content, combining it with antidiarrheal medications (such as loperamide) or prokinetic agents could produce unexpected gastrointestinal effects. No formal interaction studies exist for Apeiba tibourbou, making clinical caution advisable.

### What is the difference between Perejil del Cerro leaf preparations and root decoctions for parasites?

Ethnobotanical records distinguish between leaf extracts (traditionally prepared as infusions or teas for digestive support) and root decoctions (specifically documented for antihelminthic activity against intestinal parasites in Central and South American traditional medicine). Root preparations may contain different active compound profiles or concentrations compared to leaf material, though comparative phytochemical analysis between the two plant parts has not been published. The root decoction tradition suggests stronger antiparasitic efficacy, but this distinction remains empirical rather than clinically validated.

### Who should avoid Perejil del Cerro, particularly those with existing gastrointestinal conditions?

Individuals with inflammatory bowel disease (Crohn's disease or ulcerative colitis) should exercise caution, as the herb's effect on gut motility and inflammation modulation is unvalidated and could unpredictably worsen or improve symptoms. People with acute diarrhea from bacterial infection should avoid self-treating with Perejil del Cerro without medical confirmation of the cause, since anthelmintic or motility-altering herbs may delay necessary antibiotic treatment or worsen dehydration. Pregnant and nursing women should consult a healthcare provider before use, as safety data in these populations is absent.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*